| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |